CDH1 (encodes E-cadherin) is a classical type I cadherin that mediates calcium-dependent homophilic cell-cell adhesion. As a transmembrane glycoprotein, E-cadherin is essential for maintaining tissue architecture and cellular polarity. In the nervous system, E-cadherin plays critical roles in synaptic formation, plasticity, and neuronal migration. Emerging research demonstrates that CDH1 dysfunction contributes to neurodegenerative disease pathogenesis through multiple mechanisms including synaptic integrity disruption, altered Wnt signaling, and impaired cell-cell communication.
E-cadherin is a tumor suppressor frequently lost in carcinomas, paradoxically promoting metastasis in advanced cancers. In the brain, its expression in neurons and glia makes it a key regulator of neural circuit formation and function. The cadherin-catenin complex at synaptic junctions represents a critical hub for trans-synaptic signaling and structural maintenance.
E-cadherin is a type I transmembrane glycoprotein composed of distinct functional domains:
Extracellular Domain (residues 1-707): Contains five tandem cadherin repeats (EC1-EC5), each approximately 110 amino acids. The EC1 domain mediates homophilic binding specificity. Calcium ions bind between adjacent repeats, stabilizing the ectodomain in a rigid, rod-like conformation essential for adhesion. Each repeat contains conserved DXNDN and DXD motifs coordinating calcium.
Transmembrane Domain (residues 708-738): A single-pass helical anchor that positions the extracellular and intracellular domains on opposite sides of the plasma membrane.
Cytoplasmic Domain (residues 739-882): The intracellular region comprises three conserved regions:
E-cadherin forms both cis-dimers (between molecules on the same cell) and trans-dimers (between molecules on adjacent cells). The trans interaction involves insertion of a tryptophan residue from the EC1 domain into a hydrophobic pocket on the partner molecule. This "strand-swap" dimerization is the fundamental basis of cadherin-mediated adhesion.
The cytoplasmic domain recruits multiple catenin proteins:
In epithelial tissues, E-cadherin forms the core of adherens junctions, creating continuous adhesion belts around cells. This organizes the actin cytoskeleton, maintains epithelial polarity, and establishes contact inhibition of proliferation. The tight regulation of E-cadherin-mediated adhesion is essential for tissue homeostasis.
In the nervous system, E-cadherin is prominently expressed at synaptic junctions, particularly in dendritic spines and presynaptic terminals. Key functions include:
Synaptic Assembly: During development, E-cadherin-mediated adhesion initiates synapse formation. The cadherin-catenin complex clusters at nascent synaptic contacts, recruiting additional synaptic proteins.
Spine Morphogenesis: E-cadherin regulates dendritic spine shape and stability. The dynamic regulation of spine E-cadherin allows structural plasticity essential for learning and memory.
Synaptic Transmission: The cadherin-catenin complex interacts with neurotransmitter receptors and signaling molecules, modulating synaptic strength and plasticity.
Synaptic Junctional Complexity: At excitatory synapses, E-cadherin colocalizes with postsynaptic density proteins and contributes to the organization of the postsynaptic density.
E-cadherin plays essential roles in early neural development:
Neural Tube Formation: Cell-cell adhesion via E-cadherin is required for the epithelial-to-mesenchymal transition during neural tube closure.
Neuronal Migration: During cortical development, E-cadherin-mediated adhesion guides migrating neurons along radial glial cells.
Axon Guidance: Growth cones express E-cadherin and respond to guidance cues that alter cadherin-mediated adhesion.
Dendrite Arborization: E-cadherin regulates the branching pattern of dendritic arbors through dynamic adhesion sites.
E-cadherin sequesters β-catenin at the plasma membrane, preventing its nuclear translocation and transcriptional activity. This serves two purposes:
Alzheimer's disease (AD) is characterized by early synaptic loss that correlates with cognitive decline. E-cadherin dysfunction emerges as a significant contributor to synaptic pathology:
Amyloid-β Effects: Amyloid-β oligomers directly disrupt E-cadherin-mediated adhesion. Studies demonstrate that Aβ42 oligomers bind to the extracellular domain of E-cadherin, interfering with trans-dimer formation and weakening synaptic junctions. This disruption occurs before significant synapse loss, suggesting a causative role[1].
Cadherin-Catenin Complex Alteration: Post-mortem AD brain tissue shows reduced E-cadherin and β-catenin at synaptic membranes. The dissociation of the cadherin-catenin complex contributes to:
Synaptic Membrane Recycling: E-cadherin turnover is enhanced in AD, with increased endocytosis and reduced surface expression. This compromises synaptic junctional integrity and contributes to spine loss.
The microtubule-associated protein tau pathologies in AD may interact with E-cadherin function:
β-catenin accumulation in AD brains reflects both E-cadherin loss and altered Wnt signaling:
E-cadherin represents a potential therapeutic target in AD:
Parkinson's disease (PD) involves selective loss of dopaminergic neurons in the substantia nigra pars compacta. E-cadherin expression in these neurons relates to their vulnerability:
Lewy bodies, the characteristic protein inclusions in PD, contain cell adhesion molecules:
E-cadherin signaling influences mitochondrial dynamics in neurons:
E-cadherin alterations appear in ALS:
While primarily demyelinating, MS involves neuronal dysfunction:
CDH1 expression is epigenetically regulated:
E-cadherin interacts with other synaptic adhesion systems:
E-cadherin is a key component of the neurovascular unit:
E-cadherin is released in neuronal exosomes:
E-cadherin turnover is regulated by autophagy:
E-cadherin (CDH1) is a critical cell adhesion molecule with essential roles in synaptic function and neuronal development. In neurodegenerative diseases including Alzheimer's and Parkinson's, E-cadherin dysfunction contributes to synaptic loss, altered signaling, and neuronal vulnerability. The cadherin-catenin complex represents a therapeutic target for preserving synaptic integrity and potentially slowing disease progression. Understanding the precise mechanisms of E-cadherin dysfunction may yield novel interventions for these devastating disorders.
Liu L, Wang Y, Zhang J. Amyloid-beta disrupts cadherin-mediated synaptic adhesion. Cellular and Molecular Neurobiology. 2020. ↩︎